Cargando…

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Patel, Jyoti K, Whitehead, Kevin K, Harris, Matthew A, Keller, Marc S, Kramer, Christopher M, Epstein, Frederick H, Lin, Kimberly Y, Rossano, Joseph W, Fogel, Mark A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328990/ http://dx.doi.org/10.1186/1532-429X-17-S1-P287

Ejemplares similares

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
por: El-Zarea, Gehan Abd El-Rahman, et al.
Publicado: (2016)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
por: Haland, Trine F., et al.
Publicado: (2016)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?
por: Wang, Yunhong, et al.
Publicado: (2022)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
por: Kuno, Toshiki, et al.
Publicado: (2017)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Genetic Test for Dilated and Hypertrophic Cardiomyopathies: Useful or Less Than Useful for Patients?
por: Pastore, F, et al.
Publicado: (2013)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
por: Gulati, Ankur, et al.
Publicado: (2012)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

“Burnt out” dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis
por: Sivathasan, Cumaraswamy, et al.
Publicado: (2015)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy is associated with dilated sinus of Valsalva: A case-control study
por: Yoon, Ji Ae, et al.
Publicado: (2023)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
por: Sado, Daniel M, et al.
Publicado: (2011)

Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity
por: Stollberger, Claudia, et al.
Publicado: (2015)

Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden
por: Ricci, Fabrizio, et al.
Publicado: (2022)

Impact of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Risk
por: Yang, Jianmin, et al.
Publicado: (2013)

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
por: Tadros, Rafik, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
por: Nguyen, Christopher, et al.
Publicado: (2015)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Dual apical hypertrophic cardiomyopathy and endomyocardial fibrosis pathology
por: Martini, Chiara, et al.
Publicado: (2023)

Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy
por: Rixon, Chloe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfsmjddqveh4vr5rmnbfko8rgo